Pređi na sadržaj

Tinglong Dai

S Vikipedije, slobodne enciklopedije
Tinglong Dai
Veb-sajttinglongdai.com

Tinglong Dai je profesor operacionog menadžmenta i poslovne analitike u poslovnoj školi Carey koja pripada Univerzitetu John Hopkins, stručnjak je u oblastima zdravstvene analitike,  upravljanja globalnim lancem snabdevanja , interfejsa između marketinga i operacionog menadžmenta i interakcija između ljudi i robota.[1] U Svojim istraživanjama prvenstveno ispituje zdravlje ekosistema koristeći analitički pristup, fokusirajući se na pitanja ponašanja, podsticaja i politike u okviru operacionog menadžmenta zdravstvene zaštite.[2][3]

U najvećoj meri je radio na analizi i projektovanju lanaca nabavke vakcina, uključujući i ugovaranje vakcine protiv gripa,[4] vakcinaciju protiv virusa Covid-19,[5][6][7][8] i na proizvodnji naredne generacije vakcina.[9] Smatra se jednim od najistaknutijih eksperata u oblasti distribucije vakcina.[10]

Karijera[uredi | uredi izvor]

Tinglong Dai je stekao zvanje inženjera   u oblasti automatizacije na Univerzitetu Tongji 2004. godine,  postdiplomske studije u oblasti industrijskog inženjerstva završio je na Univerzitetu nauke i tehnologije u Hong Kongu 2006. godine, dok je 2013. godine stekao  zvanje doktora nauka u oblasti operacionog menadžmenta i robotike na Univerzitetu Carnegie Mellon, pod mentorstvom Šridara Tajura i Katje Sikare.

Pridružio se fakultetu John Hopkins 2013. godine kao docent u poslovnoj školi Carey , na kojem je 2018. godine unapređen za vanrednog profesora, a 2021. godine je dobio zvanje redovnog profesora. Poslovno obrazovni  internet stranicu Poets & Quants proglasio ga je jednim od 40 najboljih profesora na svetu u oblasti poslovanja  koji imaju manje od 40 godina.[11][12] Dva puta je osvojio nagradu... Zahvaljujući multidisciplinarna istraživanja o donošenju  odluka u oblasti medicine dva puta je osvojio John Hopkins nagradu za otkrića, prvi put  2015. godine, a zatim i 2020. godine.[13][14][14]

Dai je jedan od osnivača medicinske škole Džon Hopkins pri istoimenom Univerzitetu. Deo je liderskog tima na nivou niverziteta John Hopkins za zdravstvenu inicijativu (engl. Hopkins Business of Health Initiative)[15] i izvršnog odbora Instituta za nauku i inženjering velikih skupova podataka (eng. Institute for Data Intensive Engineering and Science).[16]

Radio je u redakciji časopisa Manufacturing & Service Operations Management, Production and Operations Management, Naval Research Logistics i Health Care Management Science.

Naučni rad[uredi | uredi izvor]

Poznat je po radu na pitanjima ponašanja, podsticaja i politike u upravljanju aktivnostima koje sprovode ustanove koje pružaju zdravstvene usluge.[17] Njegov rad se primenjuje u različitim područjima, a posebno se ističe u lancima snabdevanja vakcina,[4][18] vakcinaciji,[19] donaciji i transplataciji organa,[20][21] dijagnostičkom odlučivanju[22][23] i uključivanju veštačke inteligencije u pružanje zdravstvene zaštite.[24] Njegova istraživanja se pojavljuju u vodećim naučnim časopisima, uključujući Management Science, Manufacturing & Service Operations Management, Marketing Science i Operations Research. Osvojio je prvo mesto na takmičenju za najbolji naučni rad u oblasti operacionog menadžmenta zdravstvene zaštite koje je održao koledž za operacioni menadžment zdravstvene zaštite Production and Operations Management Society-ja, u  INFORMS takmičenju za najbolji naučni rad u oblasti operacionih istraživanja državnog sektora i INFORMS Pierskalla Award za najbolji naučni rad u zdravstvenoj zaštiti, kao i druge nagrade za najbolje naučne radove.[1]

Tokom pandemije Covid-19, Dai je opširno pisao i držao govore o važnosti i sredstvima poboljšanja otpornosti i transparentnosti lične zaštitne opreme u Americi i snabdevanju istih.[25][26][27][28][29][30][31][3] Citirajući članak u časopisu Fortune Magazine iz 2021. godine „Dai se istrajno zalagao da učini lance snabdevanja transparentnijim nego što već jesu.“[32]

Što se tiče povezanosti između marketinga i operacionog menadžmenta, Daijev rad je među prvima predstavio ograničenja u logistici kompenzacionih prodajnih snaga kroz seriju studija o vezi između oslobađanja rizika usled osiguranja i problema poslovnih odnosa između vlasnika i menadžera kompanije.[33][34][35][36]

U saradnji sa Šridarom Tajurom je uredio priručnik o zdravstvenoj analitici pod nazivom Handbook of Healthcare Analytics: Theoretical Minimum for Conducting 21st Century Research on Healthcare Operations, koji je objavila izdavačka kuća John Wiley & Sons 2018. godine.[37]

Pojavljivanje u medijima[uredi | uredi izvor]

Citirali su ga stotinama puta u popularnim medijima poput Associated Press,[38][39] Bloomberg News,[40] CNN,[41][42] Fortune,[43][44][45][46][47] The New York Times,[48][49][50][51][52][53][54][55] NPR,[56] USA Today,[57][58][59] The Wall Street Journal,[60] i The Washington Post,[61][62] takođe se pojavljivao na domaćim i inostranim TV programima poput CNBC,[63] PBS NewsHour,[3] i Sky News. U 2021. godini  internet stranica Poets & Quants proglasio ga je jednim od 40 najboljih profesora na svetu u oblasti poslovanja  koji imaju manje od 40 godina.[11][64]

Reference[uredi | uredi izvor]

  1. ^ a b "Tinglong Dai, PhD | Johns Hopkins Carey Business School". carey.jhu.edu. Pristupljeno 4. 9. 2021.
  2. ^ "Research & Beyond - Tinglong Dai". Pristupljeno 5. 9. 2021.
  3. ^ a b v "China dominates the pandemic PPE market. What does that mean for U.S. as virus surges?". PBS NewsHour. 2020-10-27. Pristupljeno 5. 9. 2021.
  4. ^ a b Dai, Tinglong; Cho, Soo-Haeng; Zhang, Fuqiang (2016). „Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain”. Manufacturing & Service Operations Management. 18 (3): 332—346. ISSN 1523-4614. doi:10.1287/msom.2015.0574. 
  5. ^ Mak, Ho-Yin; Dai, Tinglong; Tang, Christopher S. (2021). „Managing Two-Dose COVID-19 Vaccine Rollouts with Limited Supply”. doi:10.2139/ssrn.3790836. .
  6. ^ Dai, Tinglong; Song, Jing-Sheng (2021). „Transforming COVID-19 vaccines into vaccination”. Health Care Management Science. 24 (3): 455—459. ISSN 1572-9389. PMC 8206869 Slobodan pristup. PMID 34132977. S2CID 235449486. doi:10.1007/s10729-021-09563-3. .
  7. ^ Dai, Tinglong; Tang, Christopher (2021-07-21). "How to Build a Coronavirus Vaccine Supply Chain". Bloomberg Law. Pristupljeno 11. 9. 2021.
  8. ^ Dai, Tinglong (2021-02-23). "How to fix the mess of COVID-19 vaccine appointment scheduling". Fast Company. Pristupljeno 11. 9. 2021.
  9. ^ Liljenquist, Dan; Dai, Tinglong; Bai, Ge (2021). „A Nonprofit Public Utility Approach to Enhance Next-Generation Vaccine Manufacturing Capacity”. Population Health Management. 24 (5): 546—547. ISSN 1942-7891. PMID 33646049. S2CID 232079491. doi:10.1089/pop.2020.0377. .
  10. ^ "Q&A with Johns Hopkins University professor, the US top vaccine distribution expert". Pristupljeno 5. 9. 2021.
  11. ^ a b Allen, Nathan (2021-05-03). "Poets&Quants | Poets&Quants' Best 40-Under-40 Business School Professors Of 2021". Poets&Quants. Pristupljeno 5. 9. 2021.
  12. ^ Allen, Nathan (2021-05-03). "Poets&Quants | 2021 Best 40-Under-40 Professors: Tinglong Dai, Johns Hopkins University (Carey)". Poets&Quants. Pristupljeno 5. 9. 2021.
  13. ^ "Johns Hopkins Discovery Awards: 2015 Awardees". Johns Hopkins University. 2015-07-06. Pristupljeno 11. 9. 2021.
  14. ^ a b "Johns Hopkins Discovery Awards: 2020 Awardees". Johns Hopkins University. 2020-12-07. Pristupljeno 11. 9. 2021.
  15. ^ "Hopkins Business of Health Initiative". hbhi.jhu.edu. Pristupljeno 5. 9. 2021.
  16. ^ "The Institute of Data Intensive Engineering and Science". Pristupljeno 4. 9. 2021.
  17. ^ Dai, Tinglong; Tayur, Sridhar (2020). „OM Forum—Healthcare Operations Management: A Snapshot of Emerging Research”. Manufacturing & Service Operations Management. 22 (5): 869—887. ISSN 1523-4614. S2CID 169467315. doi:10.1287/msom.2019.0778. 
  18. ^ Dai, Tinglong; Song, Jing-Sheng (2021). „Transforming COVID-19 vaccines into vaccination”. Health Care Management Science. 24 (3): 455—459. ISSN 1572-9389. PMC 8206869 Slobodan pristup. PMID 34132977. S2CID 235449486. doi:10.1007/s10729-021-09563-3. 
  19. ^ Mak, Ho-Yin; Dai, Tinglong; Tang, Christopher S. (2021). „Managing Two-Dose COVID-19 Vaccine Rollouts with Limited Supply”. doi:10.2139/ssrn.3790836. 
  20. ^ Dai, Tinglong; Zheng, Ronghuo; Sycara, Katia (2020). „Jumping the Line, Charitably: Analysis and Remedy of Donor-Priority Rule”. Management Science. 66 (2): 622—641. ISSN 0025-1909. S2CID 54028044. doi:10.1287/mnsc.2018.3266. 
  21. ^ Wang, Guihua; Zheng, Ronghuo; Dai, Tinglong (2022). „Does Transportation Mean Transplantation? Impact of New Airline Routes on Sharing of Cadaveric Kidneys”. Management Science. 68 (5): 3660—3679. ISSN 0025-1909. doi:10.1287/mnsc.2021.4103. 
  22. ^ Dai, Tinglong; Wang, Xiaofang; Hwang, Chao-Wei (2022). „Clinical Ambiguity and Conflicts of Interest in Interventional Cardiology Decision Making”. Manufacturing & Service Operations Management. 24 (2): 864—882. ISSN 1523-4614. S2CID 237642935. doi:10.1287/msom.2021.0969. 
  23. ^ Dai, Tinglong; Akan, Mustafa; Tayur, Sridhar (2017). „Imaging Room and Beyond: The Underlying Economics Behind Physicians' Test-Ordering Behavior in Outpatient Services”. Manufacturing & Service Operations Management. 19 (1): 99—113. ISSN 1523-4614. S2CID 10713559. doi:10.1287/msom.2016.0594. 
  24. ^ Dai, Tinglong; Singh, Shubhranshu (2020). „Conspicuous by Its Absence: Diagnostic Expert Testing Under Uncertainty”. Marketing Science. 39 (3): 540—563. ISSN 0732-2399. doi:10.1287/mksc.2019.1201. .
  25. ^ Bai, Ge; Dai, Tinglong; Rajgopal, Shivaram (2020-07-25). "Commentary: The PPE supply chain is a black box—that needs to change". Fortune. Pristupljeno 5. 9. 2021.
  26. ^ Dai, Tinglong; Bai, Ge; Anderson, Gerard F. (2020). „PPE Supply Chain Needs Data Transparency and Stress Testing”. Journal of General Internal Medicine. 35 (9): 2748—2749. ISSN 0884-8734. PMC 7326307 Slobodan pristup. PMID 32607934. doi:10.1007/s11606-020-05987-9. .
  27. ^ Dai, Tinglong; Zaman, Muhammad H.; Padula, William V.; Davidson, Patricia M. (2021). „Supply chain failures amid Covid‐19 signal a new pillar for global health preparedness”. Journal of Clinical Nursing. 30 (1–2): e1—e3. ISSN 0962-1067. PMC 7361462 Slobodan pristup. PMID 32620038. S2CID 220336304. doi:10.1111/jocn.15400. 
  28. ^ Dai, Tinglong (2020-07-15). "Where does your PPE come from? A lack of transparency is hurting Americans". Fast Company. Pristupljeno 5. 9. 2021.
  29. ^ "The U.S. Medical Supply Chain Isn't Ready for a Second Wave". MarketWatch. Pristupljeno 5. 9. 2021.
  30. ^ Dai, Tinglong; Tang, Christopher (2020-05-27). "EETimes - Needed: A PPE Industrial Commons". EETimes. Pristupljeno 5. 9. 2021.
  31. ^ "Not Much Progress on PPE 'Reshoring'". www.medpagetoday.com. 2020-09-25. Pristupljeno 5. 9. 2021.
  32. ^ Morris, David (2021-04-23). "COVID exposed global supply chain flaws. Can Biden bring manufacturing back to the U.S.?". Fortune. Pristupljeno 5. 9. 2021.
  33. ^ Dai, Tinglong; Ke, Rongzhu; Ryan, Christopher Thomas (2021). „Incentive Design for Operations-Marketing Multitasking”. Management Science. 67 (4): 2211—2230. ISSN 0025-1909. doi:10.1287/mnsc.2020.3651. 
  34. ^ Dai, Tinglong; Jerath, Kinshuk (2019). „Salesforce Contracting Under Uncertain Demand and Supply: Double Moral Hazard and Optimality of Smooth Contracts”. Marketing Science. 38 (5): 852—870. ISSN 0732-2399. doi:10.1287/mksc.2019.1171. .
  35. ^ Dai, Tinglong; Jerath, Kinshuk (2016). „Technical Note—Impact of Inventory on Quota-Bonus Contracts with Rent Sharing”. Operations Research. 64 (1): 94—98. ISSN 0030-364X. doi:10.1287/opre.2015.1461. .
  36. ^ Dai, Tinglong; Jerath, Kinshuk (2013). „Salesforce Compensation with Inventory Considerations”. Management Science. 59 (11): 2490—2501. ISSN 0025-1909. doi:10.1287/mnsc.2013.1809. .
  37. ^ "Handbook of Healthcare Analytics: Theoretical Minimum for Conducting 21st Century Research on Healthcare Operations | Wiley". Wiley.com. Pristupljeno 5. 9. 2021.
  38. ^ "Hunt for vaccine slots often leads through scheduling maze". AP NEWS. 2021-04-20. Pristupljeno 5. 9. 2021.
  39. ^ "Vaccine storage issues could leave 3B people without access". AP NEWS. 2021-04-20. Pristupljeno 5. 9. 2021.
  40. ^ "States Craft Vaccine Plans in a Haze of Changing Information". Bloomberg.com. 2020-12-04. Pristupljeno 5. 9. 2021.
  41. ^ Madhok, Diksha. "India's Covid-19 catastrophe could hurt global supplies of medicines, clothing and shoes". CNN. Pristupljeno 5. 9. 2021.
  42. ^ Isidore, Chris. "Here's what Covid vaccines are worth to Big Pharma". CNN. Pristupljeno 5. 9. 2021.
  43. ^ "COVID exposed global supply chain flaws. Can Biden bring manufacturing back to the U.S.?". Fortune. Pristupljeno 5. 9. 2021.
  44. ^ "Karen Lynch got the big job at CVS. Now comes the big challenge: Vaccinate America". Fortune. Pristupljeno 5. 9. 2021.
  45. ^ "With billions spent and 'wartime' declared, why are vaccines still in short supply?". Fortune. Pristupljeno 5. 9. 2021.
  46. ^ "Pfizer's extra vaccine dose is more of a mess than a miracle". Fortune. Pristupljeno 5. 9. 2021.
  47. ^ "Pfizer's COVID vaccine comes with a chilly complication. But that may change". Fortune. Pristupljeno 5. 9. 2021.
  48. ^ Pérez-Peña, Richard (2021-05-03). "How Hard Could It Be to Vaccinate the Whole World? This Hard". The New York Times. ISSN 0362-4331. Pristupljeno 5. 9. 2021.
  49. ^ Robbins, Rebecca (2021-04-05). "Walgreens Not Following U.S. Guidance on Pfizer Vaccine Spacing". The New York Times. ISSN 0362-4331. Pristupljeno 5. 9. 2021.
  50. ^ Shear, Michael D.; Jewett, Christina; Swanson, Ana (2022-05-19). "Big Questions Remain About White House Plan to Speed Formula to Shelves". The New York Times. ISSN 0362-4331. Pristupljeno 20. 5. 2022.
  51. ^ Goldberg, Emma; Hirsch, Lauren; McCabe, David (2022-01-12). "Why Some Workers Are Getting All the Covid Tests They Need". The New York Times. ISSN 0362-4331. Pristupljeno 20. 5. 2022.
  52. ^ Swanson, Ana (2022-01-12). "Supply chain snags continued to drive up prices in December". The New York Times. ISSN 0362-4331. Pristupljeno 20. 5. 2022.
  53. ^ Sorkin, Andrew Ross; Karaian, Jason; Kessler, Sarah; Gandel, Stephen; Merced, Michael J. de la; Hirsch, Lauren; Livni, Ephrat (2022-01-06). "How Corporate America Has Changed After the Capitol Attack". The New York Times. ISSN 0362-4331. Pristupljeno 20. 5. 2022.
  54. ^ Smialek, Jeanna; Swanson, Ana (2022-01-12). "Consumer prices popped again in December, casting a shadow over the economy". The New York Times. ISSN 0362-4331. Pristupljeno 20. 5. 2022.
  55. ^ Shear, Michael D.; Jewett, Christina; Swanson, Ana (2022-05-19). "Big Questions Remain About White House Plan to Speed Formula to Shelves". The New York Times. ISSN 0362-4331. Pristupljeno 1. 6. 2022.
  56. ^ "Bad Batch Of Johnson & Johnson Vaccines Sets Back Production". NPR.org. Pristupljeno 5. 9. 2021.
  57. ^ Weise, Elizabeth. "'Mind-bogglingly complex': Here's what we know about how COVID-19 vaccine will be distributed when it's approved". USA TODAY. Pristupljeno 5. 9. 2021.
  58. ^ Miller, Ryan W. "How will you be told when it's your turn for a COVID-19 vaccine? It's complicated". USA TODAY. Pristupljeno 5. 9. 2021.
  59. ^ Weise, Elizabeth. "'Vaccine angels' can only do so much: US struggles to make it easier to find COVID-19 vaccination appointments". USA TODAY. Pristupljeno 5. 9. 2021.
  60. ^ Loftus, Peter; Burton, Thomas (2021-04-01). "FDA Probes Cause of Failed Johnson & Johnson Covid-19 Vaccine Batch". Wall Street Journal. ISSN 0099-9660. Pristupljeno 5. 9. 2021.
  61. ^ Witte, Griff (2021-02-03). "Some states are racing ahead of others with their coronavirus vaccine rollouts. Their secret? Keeping it simple". Washington Post. Pristupljeno 4. 9. 2021.
  62. ^ "Biden pledges to fight new variant 'with science and speed,' as omicron cases multiply and winter outlook worsens". Washington Post. ISSN 0190-8286. Pristupljeno 18. 12. 2021.
  63. ^ "Here's how the distribution infrastructure will deploy coronavirus vaccine". CNBC. 2020-11-09. Pristupljeno 5. 9. 2021.
  64. ^ Allen, Nathan (2021-05-03). "Poets&Quants | 2021 Best 40-Under-40 Professors: Tinglong Dai, Johns Hopkins University (Carey)". Poets&Quants. Pristupljeno 5. 9. 2021.
Preuzeto iz „https://sr.wikipedia.org/w/index.php?title=Тинглонг_Даи&oldid=27815759”